Metastatic Castration-resistant Prostate Cancer Clinical Trials Database - Free Access to 77 Studies
Access comprehensive clinical trial information for Metastatic Castration-resistant Prostate Cancer through Pure Global AI's free database. This collection includes 77 clinical trials across multiple phases including Phase 1, Phase 2, N/A. Currently, 36 trials are actively recruiting participants.
Research for Metastatic Castration-resistant Prostate Cancer is being conducted in United States of America, China, Switzerland and 7+ other countries. Leading sponsors include AstraZeneca and Peking Union Medical College Hospital. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
FPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)
A Phase 1/2 Study of 177Lu-NYM032 Injection in mCRPC
Real-World Clinical Experience of Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Olaparib + Abiraterone (PROceed)
Intestinal Akkermansia Muciniphila in Prostate Cancer
Study of SX-682 Plus Enzalutamide in Men With Abiraterone-Resistant Metastatic Castration Resistant Prostate Cancer
177Lu-LNC1011 in Patients With Metastatic Castration-resistant Prostate Cancer
A Phase I Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in mCRPC Patients
Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
A Study to Learn How Safe the Study Treatment Actinium-225-macropa-pelgifatamab (BAY3546828) is, How it Affects the Body, How it Moves Into, Through and Out of the Body, and About Its Anticancer Activity in Men With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)
PRostate Olaparib Real World Evidence Study
Bortezomib in Patients With Metastatic Castration-Resistant Prostate Cancer With PTEN Deletion
Clinical Study on the Efficacy and Safety of RC48-ADC in the Treatment of Metastatic Castration Resistant Prostate Cancer (mCRPC)
A Clinical Study of ONCT-534 in Subjects With Metastatic Castration-resistant Prostate Cancer.
Use of SPECT-CT for Comparison of Dosimetry Methods in PSMA-targeted Radioligand Therapy (SPECTacular Study)
Docetaxel or Cabazitaxel With or Without Darolutamide in mCRPC
Phase 0/1 Study of 212Pb-NG001 in mCRPC
ONC-392 Plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients With mCRPC
Dose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer
Pure Global AI provides free access to 77 clinical trials studying Metastatic Castration-resistant Prostate Cancer, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include AstraZeneca, Peking Union Medical College Hospital, University of Utah, among others.